Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?

PMID: 36000018
Journal: Clinical and Translational Allergy
Year: 2022
Reference: Clin Transl Allergy. 2022 Aug 20;12(8):e12182. doi: 10.1002/clt2.12182. eCollection 2022 Aug.
Impact factor:
Publication type: Paper in international publication
Authors: Arismendi, Ebymar; Barranco, Pilar; Barroso, Blanca; Betancor, Diana; Bobolea, Irina; Cardaba, Blanca; Cruz, Maria Jesus; Curto, Elena; Del Pozo, Victoria; Gonzalez-Barcala, Francisco-Javier et al.
DOI: 10.1002/clt2.12182

How to Identify Invasive Candidemia in ICU-A Narrative Review.

PMID: 36551461
Journal: Antibiotics-Basel
Year: 2022
Reference: Antibiotics (Basel). 2022 Dec 12;11(12):1804. doi: 10.3390/antibiotics11121804.
Impact factor:
Publication type: Review in international publication
Authors: Alonso-Tarres, Carles; Alves, Joana; Rello, Jordi et al.
DOI: 10.3390/antibiotics11121804

How to interpret viral markers in the management of chronic hepatitis B infection.

PMID: 34768018
Journal: CLINICAL MICROBIOLOGY AND INFECTION
Year: 2022
Reference: Clin Microbiol Infect. 2022 Mar;28(3):355-361. doi: 10.1016/j.cmi.2021.10.020. Epub 2021 Nov 9.
Impact factor: 8.067
Publication type: Review in international publication
Authors: Riveiro-Barciela, Mar, Pericas, Juan M, Buti, Maria et al.
DOI: 10.1016/j.cmi.2021.10.020

How to interpret viral markers in the management of chronic hepatitis B infection.

PMID: 34768018
Journal: CLINICAL MICROBIOLOGY AND INFECTION
Year: 2022
Reference: Clin Microbiol Infect. 2022 Mar;28(3):355-361. doi: 10.1016/j.cmi.2021.10.020. Epub 2021 Nov 9.
Impact factor:
Publication type: Review in international publication
Authors: Buti, Maria; Pericas, Juan M; Riveiro-Barciela, Mar et al.
DOI: 10.1016/j.cmi.2021.10.020

HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience.

PMID: 36146780
Journal: Viruses-Basel
Year: 2022
Reference: Viruses. 2022 Sep 6;14(9). pii: v14091975. doi: 10.3390/v14091975.
Impact factor:
Publication type: Paper in international publication
Authors: Bes, Marta; Caballero, Estrella; Casamitjana, Natalia; Molina, Israel; Piron, Maria; Puig, Lluis; Salvador, Fernando; Sanchez-Montalva, Adrian; Sauleda, Silvia et al.
DOI: 10.3390/v14091975

Human alpha-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.

PMID: 35210396
Journal: Translational Psychiatry
Year: 2022
Reference: Transl Psychiatry. 2022 Feb 24;12(1):79. doi: 10.1038/s41398-022-01842-z.
Impact factor: 6.222
Publication type: Paper in international publication
Authors: Campa, Leticia, Miquel-Rio, Lluis, Alarcon-Aris, Diana, Torres-Lopez, Maria, Coppola-Segovia, Valentin, Pavia-Collado, Ruben, Paz, Veronica, Ruiz-Bronchal, Esther, Vila, Miquel, Artigas, Francesc et al.
DOI: 10.1038/s41398-022-01842-z

Human alpha-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.

PMID: 35210396
Journal: Translational Psychiatry
Year: 2022
Reference: Transl Psychiatry. 2022 Feb 24;12(1):79. doi: 10.1038/s41398-022-01842-z.
Impact factor:
Publication type: Paper in international publication
Authors: Alarcon-Aris, Diana; Artigas, Francesc; Bortolozzi, Analia; Campa, Leticia; Casal, Carme; Coppola-Segovia, Valentin; Miquel-Rio, Lluis; Montefeltro, Andres; Pavia-Collado, Ruben; Paz, Veronica et al.
DOI: 10.1038/s41398-022-01842-z

Human genetic and immunological determinants of critical COVID-19 pneumonia.

PMID: 35090163
Journal: NATURE
Year: 2022
Reference: Nature. 2022 Mar;603(7902):587-598. doi: 10.1038/s41586-022-04447-0. Epub 2022 Jan 28.
Impact factor: 49.962
Publication type: Review in international publication
Authors: Drolet, Beth A, Aiuti, Alessandro, Belot, Alexandre, Bolze, Alexandre, Gaudet, Alexandre, Bondarenko, Anastasiia, Spaan, Andras N, Guennoun, Andrea, Arias, Andres Augusto, Planas, Anna M et al.
DOI: 10.1038/s41586-022-04447-0

Human genetic and immunological determinants of critical COVID-19 pneumonia.

PMID: 35090163
Journal: NATURE
Year: 2022
Reference: Nature. 2022 Mar;603(7902):587-598. doi: 10.1038/s41586-022-04447-0. Epub 2022 Jan 28.
Impact factor:
Publication type: Review in international publication
Authors: Abel, Laurent; Aiuti, Alessandro; Akcan, Ozge Metin; Akcay, Nihal; Alexander, Natalie; Alkan, Gulsum; Allende, Luis M; Alsohime, Fahad; Anaya, Juan Manuel; Anderson, Mark S et al.
DOI: 10.1038/s41586-022-04447-0

Human gut metatranscriptome changes induced by a fermented milk product are associated with improved tolerance to a flatulogenic diet.

PMID: 35465165
Journal: Computational and Structural Biotechnology Journal
Year: 2022
Reference: Comput Struct Biotechnol J. 2022 Apr 5;20:1632-1641. doi: 10.1016/j.csbj.2022.04.001. eCollection 2022.
Impact factor: 7.271
Publication type: Paper in international publication
Authors: Oyarzun, Inigo, Le Neve, Boris, Yanez, Francisca, Xie, Zixuan, Pichaud, Matthieu, Serrano-Gomez, Gerard, Roca, Joaquim, Veiga, Patrick, Azpiroz, Fernando, Tap, Julien et al.
DOI: 10.1016/j.csbj.2022.04.001

Human gut metatranscriptome changes induced by a fermented milk product are associated with improved tolerance to a flatulogenic diet.

PMID: 35465165
Journal: Computational and Structural Biotechnology Journal
Year: 2022
Reference: Comput Struct Biotechnol J. 2022 Apr 5;20:1632-1641. doi: 10.1016/j.csbj.2022.04.001. eCollection 2022.
Impact factor:
Publication type: Paper in international publication
Authors: Azpiroz, Fernando; Le Neve, Boris; Manichanh, Chaysavanh; Oyarzun, Inigo; Pichaud, Matthieu; Roca, Joaquim; Serrano-Gomez, Gerard; Tap, Julien; Veiga, Patrick; Xie, Zixuan et al.
DOI: 10.1016/j.csbj.2022.04.001

Human pericardial extracellular matrix: An implantation platform for cardiac tissue engineering

PMID: NOPMID0095
Journal: Frontiers in Biomaterials Science
Year: 2022
Reference: Frontiers in Biomaterials Science, 1. https://doi.org/10.3389/fbiom.2022.953837
Impact factor:
Publication type: Paper in international publication
Authors: Bayes-Genis, Antoni; Castells-Sala, Cristina; Fariñas, Oscar; López-Chicón, Patricia; Prat-Vidal, Cristina; Rodríguez-Gómez, Luciano; Roura, Santiago; Vilarrodona, Anna et al.
DOI: 10.3389/fbiom.2022.953837

Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease.

PMID: 36409773
Journal: PLoS Neglected Tropical Diseases
Year: 2022
Reference: PLoS Negl Trop Dis. 2022 Nov 21;16(11):e0010828. doi: 10.1371/journal.pntd.0010828. eCollection 2022 Nov.
Impact factor:
Publication type: Paper in international publication
Authors: Buckee, Caroline O; De Salazar, Pablo M; Molina, Israel; Ribeiro, Isabela; Salvador, Fernando; Sanchez-Montalva, Adrian; Sosa-Estani, Sergio; Sulleiro, Elena et al.
DOI: 10.1371/journal.pntd.0010828

Humoral and cellular response in convalescent COVID-19 lupus patients.

PMID: 35962159
Journal: Scientific Reports
Year: 2022
Reference: Sci Rep. 2022 Aug 12;12(1):13787. doi: 10.1038/s41598-022-17334-5.
Impact factor:
Publication type: Paper in international publication
Authors: Cortes-Hernandez, Josefina; Domingo, Sandra; Sole, Cristina; Vidal, Xavier et al.
DOI: 10.1038/s41598-022-17334-5

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.

PMID: 35105687
Journal: Neurology-Neuroimmunology & Neuroinflammation
Year: 2022
Reference: Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). pii: 9/2/e1143. doi: 10.1212/NXI.0000000000001143. Print 2022 Mar.
Impact factor: 8.485
Publication type: Paper in international publication
Authors: Arrambide, Georgina; Zabalza, Ana; Nos, Carlos; Sastre-Garriga, Jaume; Tintore, Mar; Montalban, Xavier; Comabella, Manuel; Espejo, Carmen; Castillo, Joaquin; Otero-Romero, Susana et al.
DOI: 10.1212/NXI.0000000000001143

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.

PMID: 35105687
Journal: Neurology-Neuroimmunology & Neuroinflammation
Year: 2022
Reference: Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). pii: 9/2/e1143. doi: 10.1212/NXI.0000000000001143. Print 2022 Mar.
Impact factor:
Publication type: Paper in international publication
Authors: Arrambide, Georgina; Beltran, Jordina; Bonastre, Merce; Carbonell-Mirabent, Pere; Cardenas-Robledo, Simon; Castillo, Joaquin; Castillo, Mireia; Cobo-Calvo, Alvaro; Comabella, Manuel; Espejo, Carmen et al.
DOI: 10.1212/NXI.0000000000001143

Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.

PMID: 35551070
Journal: Clinical Journal of the American Society of Nephro
Year: 2022
Reference: Clin J Am Soc Nephrol. 2022 Jun;17(6):872-876. doi: 10.2215/CJN.01770222. Epub 2022 May 12.
Impact factor: 8.237
Publication type: Letter whit IF
Authors: Puerta Carretero, Marta, Jaldo Rodriguez, Maria Teresa, Carnerero Di Riso, Manuel Antonio, Martinez, Shaira, Gonzalez, Carmen Calderon, Cervienka, Michal, Macias Carmona, Nicolas, Arroyo, David, Perez Del Valle, Katia M, de Arriba, Gabriel et al.
DOI: 10.2215/CJN.01770222

Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.

PMID: 35551070
Journal: Clinical Journal of the American Society of Nephrology
Year: 2022
Reference: Clin J Am Soc Nephrol. 2022 Jun;17(6):872-876. doi: 10.2215/CJN.01770222. Epub 2022 May 12.
Impact factor:
Publication type: Letter whit IF
Authors: Aguilar Cervera, Maria Cinta; Alfaro Sanchez, Christian; Arroyo, David; Carnerero Di Riso, Manuel Antonio; Cazorla, Juan Manuel; Cervienka, Michal; Cigarran Guldris, Secundino; de Arriba, Gabriel; de Sequera, Patricia; Folgueiras Lopez, Montserrat et al.
DOI: 10.2215/CJN.01770222

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.

PMID: 35551632
Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY
Year: 2022
Reference: Int J Hematol. 2022 May 13. pii: 10.1007/s12185-022-03367-z. doi: 10.1007/s12185-022-03367-z.
Impact factor: 2.49
Publication type: Paper in international publication
Authors: Barrenetxea, Cristina, Sancho, Juan-Manuel, Marin-Niebla, Ana, Fernandez, Silvia, Capote, Francisco-Javier, Canigral, Carolina, Grande, Carlos, Donato, Eva, Zeberio, Izaskun, Puerta, Jose-Manuel et al.
DOI: 10.1007/s12185-022-03367-z

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.

PMID: 35551632
Journal: INTERNATIONAL JOURNAL OF HEMATOLOGY
Year: 2022
Reference: Int J Hematol. 2022 Sep;116(3):381-392. doi: 10.1007/s12185-022-03367-z. Epub 2022 May 13.
Impact factor:
Publication type: Paper in international publication
Authors: Arranz, Reyes; Barrenetxea, Cristina; Canigral, Carolina; Capote, Francisco-Javier; Conde-Royo, Diego; Donato, Eva; Fernandez, Silvia; Gonzalez-Barca, Eva; Grande, Carlos; Hernandez-Rivas, Jose-Angel et al.
DOI: 10.1007/s12185-022-03367-z

Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse.

PMID: 35789260
Journal: BLOOD
Year: 2022
Reference: Blood. 2022 Jul 5. pii: 485785. doi: 10.1182/blood.2022015560.
Impact factor: 23.629
Publication type: Paper in international publication
Authors: Sciarra, Roberta; Chiappella, Annalisa; Sartori, Roberto; Vitagliano, Orsola; Mannina, Donato; Morello, Lucia; Arcari, Annalisa; Nicoli, Paolo; Stefani, Piero Maria; Angelillo, Piera et al.
DOI: 10.1182/blood.2022015560

Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse.

PMID: 35789260
Journal: BLOOD
Year: 2022
Reference: Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560.
Impact factor:
Publication type: Paper in international publication
Authors: Angelillo, Piera; Arcari, Annalisa; Auer, Rebecca; Bernard, Sophie; Cencini, Emanuele; Cheah, Chan Y; Chiappella, Annalisa; Crucitti, Lara; Dlugosz-Danecka, Monika; Dreyling, Martin et al.
DOI: 10.1182/blood.2022015560

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.

PMID: 35030036
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 Apr 10;40(11):1196-1205. doi: 10.1200/JCO.21.02321. Epub 2022 Jan 14.
Impact factor: 44.544
Publication type: Paper in international publication
Authors: Gine, Eva, de la Cruz, Fatima, Jimenez Ubieto, Ana, Lopez Jimenez, Javier, Martin Garcia-Sancho, Alejandro, Terol, M Jose, Gonzalez Barca, Eva, Casanova, Maria, de la Fuente, Adolfo, Marin-Niebla, Ana et al.
DOI: 10.1200/JCO.21.02321

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.

PMID: 35030036
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 Apr 10;40(11):1196-1205. doi: 10.1200/JCO.21.02321. Epub 2022 Jan 14.
Impact factor:
Publication type: Paper in international publication
Authors: Aymerich, Marta; Bea, Silvia; Campo, Elias; Casanova, Maria; Cortes-Romera, Montserrat; de la Cruz, Fatima; de la Fuente, Adolfo; Garcia Sanz, Ramon; Gine, Eva; Gonzalez Barca, Eva et al.
DOI: 10.1200/JCO.21.02321

Publications

Publications searcher

How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?

How to Identify Invasive Candidemia in ICU-A Narrative Review.

How to interpret viral markers in the management of chronic hepatitis B infection.

How to interpret viral markers in the management of chronic hepatitis B infection.

HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience.

Human alpha-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.

Human alpha-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.

Human genetic and immunological determinants of critical COVID-19 pneumonia.

Human genetic and immunological determinants of critical COVID-19 pneumonia.

Human gut metatranscriptome changes induced by a fermented milk product are associated with improved tolerance to a flatulogenic diet.

Human gut metatranscriptome changes induced by a fermented milk product are associated with improved tolerance to a flatulogenic diet.

Human pericardial extracellular matrix: An implantation platform for cardiac tissue engineering

Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease.

Humoral and cellular response in convalescent COVID-19 lupus patients.

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.

Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.

Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.

Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse.

Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse.

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.

Patronage:

Collaborating:

Accreditations: